We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+14.51%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$156B
AUM Growth
+$25.5B
Cap. Flow
+$7.96B
Cap. Flow %
5.1%
Top 10 Hldgs %
14.45%
Holding
3,256
New
111
Increased
2,472
Reduced
419
Closed
64

Top Buys

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$443M
2
BMY icon
Bristol-Myers Squibb
BMY
+$300M
3
MSFT icon
Microsoft
MSFT
+$224M
4
AMZN icon
Amazon
AMZN
+$177M
5
DIS icon
Walt Disney
DIS
+$174M

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Financials 13.9%
3 Healthcare 13%
4 Industrials 10.42%
5 Consumer Discretionary 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBEV
3076
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$132K ﹤0.01%
25,010
PFIE
3077
DELISTED
Profire Energy, Inc
PFIE
$127K ﹤0.01%
70,425
+26,425
+60% +$46.8K
MLNT
3078
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$125K ﹤0.01%
35,090
+740
+2% +$4.02K
CHRA
3079
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$123K ﹤0.01%
1,914
+519
+37% +$36.9K
SER icon
3080
Serina Therapeutics
SER
$31M
$122K ﹤0.01%
855
+303
+55% +$44.3K
VERI icon
3081
Veritone
VERI
$92.9M
$119K ﹤0.01%
22,863
+7,563
+49% +$42.1K
NYMX
3082
DELISTED
Nymox Pharmaceutical Corp
NYMX
$119K ﹤0.01%
60,400
CFMS
3083
DELISTED
Conformis, Inc. Common Stock
CFMS
$113K ﹤0.01%
+1,563
New +$44.6K
SNNA
3084
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$113K ﹤0.01%
48,466
+17,969
+59% +$48.7K
AAC
3085
DELISTED
AAC Holdings
AAC
$113K ﹤0.01%
60,920
+3,545
+6% +$8.86K
ACGN
3086
DELISTED
Aceragen Inc
ACGN
$109K ﹤0.01%
2,502
TLGT
3087
DELISTED
Teligent, Inc
TLGT
$102K ﹤0.01%
8,720
QHC
3088
DELISTED
Quorum Health Corporation
QHC
$102K ﹤0.01%
72,416
+19,116
+36% +$51.5K
TLPH icon
3089
Talphera
TLPH
$68M
$99K ﹤0.01%
1,422
+687
+93% +$40K
SNCR
3090
DELISTED
Synchronoss Technologies
SNCR
$97K ﹤0.01%
1,762
AKAO
3091
DELISTED
Achaogen Inc
AKAO
$97K ﹤0.01%
210,696
+66,354
+46% +$69.7K
KA
3092
DELISTED
Kineta, Inc. Common Stock
KA
$95K ﹤0.01%
535
RMNI icon
3093
Rimini Street
RMNI
$457M
$94K ﹤0.01%
18,800
LUMO
3094
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$94K ﹤0.01%
5,411
ZN
3095
DELISTED
Zion Oil & Gas, Inc.
ZN
$93K ﹤0.01%
122,348
CTIC
3096
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$93K ﹤0.01%
95,500
BDSI
3097
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$89K ﹤0.01%
16,652
EQ icon
3098
Equillium
EQ
$144M
$86K ﹤0.01%
10,650
KEG
3099
DELISTED
Key Energy Services, Inc. Common Stock
KEG
$85K ﹤0.01%
20,930
MJCO
3100
DELISTED
Majesco
MJCO
$83K ﹤0.01%
+11,700
New +$86.9K

Similar funds

Charles Schwab's Q1 2019 Portfolio in Review

As of Q1 2019, Charles Schwab held 3,256 positions worth $156B, up 20% from $131B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $7.96B of net new capital in Q1 2019, opening 111 new positions and adding to 2,472 existing holdings. Its largest new stake was Fox Class A: 1,745,328 shares worth $64.1M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Walmart Inc, an estimated $356M trimmed.

  • Charles Schwab's largest Q1 2019 buy was Fox Class A: 1,745,328 shares worth $64.1M.
  • Charles Schwab added most to Coca-Cola in Q1 2019, an estimated $443M increase.
  • Charles Schwab's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $356M.
  • Charles Schwab fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $213M.
  • Charles Schwab's ten largest holdings make up 14% of its $156B portfolio in Q1 2019.
  • Charles Schwab opened 111 new positions and closed 64 in Q1 2019.
  • Charles Schwab's portfolio value rose 20% quarter-over-quarter to $156B.

Based on Charles Schwab's 13F filing for Q1 2019, filed 14 May 2019.